{"id":1853,"date":"2023-05-24T18:50:41","date_gmt":"2023-05-24T18:50:41","guid":{"rendered":"https:\/\/blogs.bmj.com\/jmg\/?p=1853"},"modified":"2026-02-23T00:12:09","modified_gmt":"2026-02-23T00:12:09","slug":"a-model-for-the-return-and-referral-of-all-clinically-significant-secondary-findings-of-genomic-sequencing","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/jmg\/2023\/05\/24\/a-model-for-the-return-and-referral-of-all-clinically-significant-secondary-findings-of-genomic-sequencing\/","title":{"rendered":"A model for the return and referral of all clinically significant secondary findings of genomic sequencing (Contributed by Rita Kodida, MS, CCGC, CGC)"},"content":{"rendered":"<p>Genomic sequencing (GS) has the capability of identifying a broad range of clinically significant secondary findings (SFs) beyond medically actionable findings. Healthcare resources and capacity constraints of returning and managing all clinically significant SFs represent major barriers to implementation of GS. We present a model for the return and referral of all clinically significant SFs initially identified in the research setting and transitioned into clinical care. By involving multiple healthcare providers (HCPs), this process aimed to decrease the burden on a single HCP to manage all of a patients\u2019 SFs. Efficient and scalable models are fundamental to facilitate the uptake of GS and advance precision medicine. (<a href=\"https:\/\/jmg.bmj.com\/content\/early\/2023\/05\/22\/jmg-2022-109091\">https:\/\/jmg.bmj.com\/content\/early\/2023\/05\/22\/jmg-2022-109091<\/a> )<!--TrendMD v2.4.8--><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Genomic sequencing (GS) has the capability of identifying a broad range of clinically significant secondary findings (SFs) beyond medically actionable findings. Healthcare resources and capacity constraints of returning and managing all clinically significant SFs represent major barriers to implementation of GS. We present a model for the return and referral of all clinically significant SFs [&#8230;]<\/p>\n<p><a class=\"btn btn-secondary understrap-read-more-link\" href=\"https:\/\/blogs.bmj.com\/jmg\/2023\/05\/24\/a-model-for-the-return-and-referral-of-all-clinically-significant-secondary-findings-of-genomic-sequencing\/\">Read More&#8230;<\/a><\/p>\n","protected":false},"author":123,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1853","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>A model for the return and referral of all clinically significant secondary findings of genomic sequencing (Contributed by Rita Kodida, MS, CCGC, CGC) - JMG Contact blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/jmg\/2023\/05\/24\/a-model-for-the-return-and-referral-of-all-clinically-significant-secondary-findings-of-genomic-sequencing\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"A model for the return and referral of all clinically significant secondary findings of genomic sequencing (Contributed by Rita Kodida, MS, CCGC, CGC) - JMG Contact blog\" \/>\n<meta property=\"og:description\" content=\"Genomic sequencing (GS) has the capability of identifying a broad range of clinically significant secondary findings (SFs) beyond medically actionable findings. Healthcare resources and capacity constraints of returning and managing all clinically significant SFs represent major barriers to implementation of GS. We present a model for the return and referral of all clinically significant SFs [...]Read More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/jmg\/2023\/05\/24\/a-model-for-the-return-and-referral-of-all-clinically-significant-secondary-findings-of-genomic-sequencing\/\" \/>\n<meta property=\"og:site_name\" content=\"JMG Contact blog\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-24T18:50:41+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-23T00:12:09+00:00\" \/>\n<meta name=\"author\" content=\"hqqu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@HuiQiQu\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"hqqu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2023\\\/05\\\/24\\\/a-model-for-the-return-and-referral-of-all-clinically-significant-secondary-findings-of-genomic-sequencing\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2023\\\/05\\\/24\\\/a-model-for-the-return-and-referral-of-all-clinically-significant-secondary-findings-of-genomic-sequencing\\\/\"},\"author\":{\"name\":\"hqqu\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\"},\"headline\":\"A model for the return and referral of all clinically significant secondary findings of genomic sequencing (Contributed by Rita Kodida, MS, CCGC, CGC)\",\"datePublished\":\"2023-05-24T18:50:41+00:00\",\"dateModified\":\"2026-02-23T00:12:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2023\\\/05\\\/24\\\/a-model-for-the-return-and-referral-of-all-clinically-significant-secondary-findings-of-genomic-sequencing\\\/\"},\"wordCount\":137,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2023\\\/05\\\/24\\\/a-model-for-the-return-and-referral-of-all-clinically-significant-secondary-findings-of-genomic-sequencing\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2023\\\/05\\\/24\\\/a-model-for-the-return-and-referral-of-all-clinically-significant-secondary-findings-of-genomic-sequencing\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2023\\\/05\\\/24\\\/a-model-for-the-return-and-referral-of-all-clinically-significant-secondary-findings-of-genomic-sequencing\\\/\",\"name\":\"A model for the return and referral of all clinically significant secondary findings of genomic sequencing (Contributed by Rita Kodida, MS, CCGC, CGC) - JMG Contact blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\"},\"datePublished\":\"2023-05-24T18:50:41+00:00\",\"dateModified\":\"2026-02-23T00:12:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2023\\\/05\\\/24\\\/a-model-for-the-return-and-referral-of-all-clinically-significant-secondary-findings-of-genomic-sequencing\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2023\\\/05\\\/24\\\/a-model-for-the-return-and-referral-of-all-clinically-significant-secondary-findings-of-genomic-sequencing\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2023\\\/05\\\/24\\\/a-model-for-the-return-and-referral-of-all-clinically-significant-secondary-findings-of-genomic-sequencing\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"A model for the return and referral of all clinically significant secondary findings of genomic sequencing (Contributed by Rita Kodida, MS, CCGC, CGC)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"name\":\"JMG Contact blog\",\"description\":\"JMG Contact blog\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\",\"name\":\"JMG Contact blog\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"width\":300,\"height\":34,\"caption\":\"JMG Contact blog\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\",\"name\":\"hqqu\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"caption\":\"hqqu\"},\"description\":\"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.\",\"sameAs\":[\"https:\\\/\\\/x.com\\\/HuiQiQu\"],\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/author\\\/hqiqu\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"A model for the return and referral of all clinically significant secondary findings of genomic sequencing (Contributed by Rita Kodida, MS, CCGC, CGC) - JMG Contact blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/jmg\/2023\/05\/24\/a-model-for-the-return-and-referral-of-all-clinically-significant-secondary-findings-of-genomic-sequencing\/","og_locale":"en_US","og_type":"article","og_title":"A model for the return and referral of all clinically significant secondary findings of genomic sequencing (Contributed by Rita Kodida, MS, CCGC, CGC) - JMG Contact blog","og_description":"Genomic sequencing (GS) has the capability of identifying a broad range of clinically significant secondary findings (SFs) beyond medically actionable findings. Healthcare resources and capacity constraints of returning and managing all clinically significant SFs represent major barriers to implementation of GS. We present a model for the return and referral of all clinically significant SFs [...]Read More...","og_url":"https:\/\/blogs.bmj.com\/jmg\/2023\/05\/24\/a-model-for-the-return-and-referral-of-all-clinically-significant-secondary-findings-of-genomic-sequencing\/","og_site_name":"JMG Contact blog","article_published_time":"2023-05-24T18:50:41+00:00","article_modified_time":"2026-02-23T00:12:09+00:00","author":"hqqu","twitter_card":"summary_large_image","twitter_creator":"@HuiQiQu","twitter_misc":{"Written by":"hqqu","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/jmg\/2023\/05\/24\/a-model-for-the-return-and-referral-of-all-clinically-significant-secondary-findings-of-genomic-sequencing\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2023\/05\/24\/a-model-for-the-return-and-referral-of-all-clinically-significant-secondary-findings-of-genomic-sequencing\/"},"author":{"name":"hqqu","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b"},"headline":"A model for the return and referral of all clinically significant secondary findings of genomic sequencing (Contributed by Rita Kodida, MS, CCGC, CGC)","datePublished":"2023-05-24T18:50:41+00:00","dateModified":"2026-02-23T00:12:09+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2023\/05\/24\/a-model-for-the-return-and-referral-of-all-clinically-significant-secondary-findings-of-genomic-sequencing\/"},"wordCount":137,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/jmg\/2023\/05\/24\/a-model-for-the-return-and-referral-of-all-clinically-significant-secondary-findings-of-genomic-sequencing\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/jmg\/2023\/05\/24\/a-model-for-the-return-and-referral-of-all-clinically-significant-secondary-findings-of-genomic-sequencing\/","url":"https:\/\/blogs.bmj.com\/jmg\/2023\/05\/24\/a-model-for-the-return-and-referral-of-all-clinically-significant-secondary-findings-of-genomic-sequencing\/","name":"A model for the return and referral of all clinically significant secondary findings of genomic sequencing (Contributed by Rita Kodida, MS, CCGC, CGC) - JMG Contact blog","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#website"},"datePublished":"2023-05-24T18:50:41+00:00","dateModified":"2026-02-23T00:12:09+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2023\/05\/24\/a-model-for-the-return-and-referral-of-all-clinically-significant-secondary-findings-of-genomic-sequencing\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/jmg\/2023\/05\/24\/a-model-for-the-return-and-referral-of-all-clinically-significant-secondary-findings-of-genomic-sequencing\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/jmg\/2023\/05\/24\/a-model-for-the-return-and-referral-of-all-clinically-significant-secondary-findings-of-genomic-sequencing\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/jmg\/"},{"@type":"ListItem","position":2,"name":"A model for the return and referral of all clinically significant secondary findings of genomic sequencing (Contributed by Rita Kodida, MS, CCGC, CGC)"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/jmg\/#website","url":"https:\/\/blogs.bmj.com\/jmg\/","name":"JMG Contact blog","description":"JMG Contact blog","publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/jmg\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/jmg\/#organization","name":"JMG Contact blog","url":"https:\/\/blogs.bmj.com\/jmg\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","contentUrl":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","width":300,"height":34,"caption":"JMG Contact blog"},"image":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b","name":"hqqu","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","caption":"hqqu"},"description":"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.","sameAs":["https:\/\/x.com\/HuiQiQu"],"url":"https:\/\/blogs.bmj.com\/jmg\/author\/hqiqu\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/1853","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/users\/123"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/comments?post=1853"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/1853\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/media?parent=1853"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/categories?post=1853"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/tags?post=1853"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}